ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,415Medicare Part D Prescriptions Filled, Including Refills

Rank: 316 out of 780

$350K Total Retail Price of All Prescriptions

Rank: 431 out of 780

404 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

5% of this provider’s 7,246 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 381 273 1 3
SIMVASTATIN 291 215 2 2
ATENOLOL-CHLORTHALIDONE 238 156 3 182
AMLODIPINE BESYLATE 236 202 4 4
LEVOTHYROXINE SODIUM 233 192 5 5
CLONIDINE HCL 225 173 6 28
FUROSEMIDE 206 159 7 7
POTASSIUM CHLORIDE 197 129 8 11
PRAVASTATIN SODIUM 183 175 9 9
GLYBURIDE-METFORMIN HCL 171 130 R 10 108
CIMETIDINE 158 121 10 11 317
CARVEDILOL 157 147 12 14
ACETAMINOPHEN-CODEINE 143 118 S3 13 116
METFORMIN HCL 136 100 14 8
ALLOPURINOL 132 100 15 29
ATORVASTATIN CALCIUM 128 102 16 12
TRIAMTERENE-HCTZ 122 103 17 37
LISINOPRIL 111 76 18 6
NIFEDIPINE ER 110 98 19 115
TRAMADOL HCL 109 81 20 15
KLOR-CON 8 108 94 21 194
FELODIPINE ER 104 87 22 126
HYDRALAZINE HCL 102 81 23 54
GLYBURIDE 100 73 R 24 101
LOSARTAN POTASSIUM 96 76 25 18
PANTOPRAZOLE SODIUM 96 86 25 25
AZITHROMYCIN 94 63 27 38
NEXIUM 91 79 28 22
KLOR-CON M20 88 88 29 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 82 30 26
ZOLPIDEM TARTRATE 84 49 31 17
HYDROCHLOROTHIAZIDE 82 61 32 10
TAMSULOSIN HCL 81 78 33 36
METOPROLOL TARTRATE 81 73 33 19
FLUTICASONE PROPIONATE 80 36 35 41
CEFACLOR 78 55 36 390
SINGULAIR 77 46 37 73
VERAPAMIL ER 77 44 37 78
ALPRAZOLAM 75 66 39 328
DIGOXIN 75 75 39 56
VENTOLIN HFA 75 30 39 91
ATENOLOL 74 56 42 21
MELOXICAM 70 60 43 16
SPIRONOLACTONE 66 44 44 53
HUMULIN 70-30 65 65 45 106
GLIPIZIDE 63 45 46 74
MECLIZINE HCL 62 59 47 83
CYPROHEPTADINE HCL 62 55 R 47 242
AMLODIPINE BESYLATE-BENAZEPRIL 60 44 49 50
LOVASTATIN 59 42 50 47
PLAVIX 59 51 50 45
METHOCARBAMOL 58 51 R 52 84
DONEPEZIL HCL 55 55 53 31
BACLOFEN 54 34 54 153
CLOPIDOGREL 54 54 54 34
BENAZEPRIL HCL 53 43 56 59
GLIMEPIRIDE 51 34 57 30
METOPROLOL SUCCINATE 50 50 58 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.